Article

Upsher-Smith Launches Haloperidol Tablets, USP

Upsher-Smith Laboratories have launched haloperidol tablets, USP the generic version of the brand product, Haldol Tablets.

Upsher-Smith Laboratories, LLC (Upsher-Smith) has announced the launch of haloperidol tablets, USP in 0.5 mg, 1 mg, 2 mg, 5 mg, 10 mg and 20 mg strengths. Haloperidol tablets are a generic version of the brand product, Haldol Tablets. The haloperidol tablet market had US sales of approximately $41 million for the 12 months ending August 2019, according to IQVIA.

Reference

Uspher-Smith launches haloperidol tablets, USP. PR Newswire website. Published January 13, 2020. https://www.prnewswire.com/news-releases/upsher-smith-launches-haloperidol-tablets-usp-300985540.html. Accessed January 14, 2020.

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Related Videos
Inflammation concept, inflammated human tissues 3d rendering - Image credit: picture-waterfall | stock.adobe.com